CONTEXT: Adequate symptom management is essential to ensure quality cancer care, but symptom management is not always evidence based. Adapting and automating national guidelines for use at the point of care may enhance use by clinicians. OBJECTIVES: This article reports on a process of adapting research evidence for use in a clinical decision support system that provided individualized symptom management recommendations to clinicians at the point of care. METHODS: Using a modified ADAPTE process, panels of local experts adapted national guidelines and integrated research evidence to create computable algorithms with explicit recommendations for management of the most common symptoms (pain, fatigue, dyspnea, depression, and anxiety) associated with lung cancer. RESULTS: Small multidisciplinary groups and a consensus panel, using a nominal group technique, modified and subsequently approved computable algorithms for fatigue, dyspnea, moderate pain, severe pain, depression, and anxiety. The approved algorithms represented the consensus of multidisciplinary clinicians on pharmacological and behavioral interventions tailored to the patient's age, comorbidities, laboratory values, current medications, and patient-reported symptom severity. Algorithms also were reconciled with one another to enable simultaneous management of several symptoms. CONCLUSION: A modified ADAPTE process and nominal group technique enabled the development and approval of locally adapted computable algorithms for individualized symptom management in patients with lung cancer. The process was more complex and required more time and resources than initially anticipated, but it resulted in computable algorithms that represented the consensus of many experts.
CONTEXT: Adequate symptom management is essential to ensure quality cancer care, but symptom management is not always evidence based. Adapting and automating national guidelines for use at the point of care may enhance use by clinicians. OBJECTIVES: This article reports on a process of adapting research evidence for use in a clinical decision support system that provided individualized symptom management recommendations to clinicians at the point of care. METHODS: Using a modified ADAPTE process, panels of local experts adapted national guidelines and integrated research evidence to create computable algorithms with explicit recommendations for management of the most common symptoms (pain, fatigue, dyspnea, depression, and anxiety) associated with lung cancer. RESULTS: Small multidisciplinary groups and a consensus panel, using a nominal group technique, modified and subsequently approved computable algorithms for fatigue, dyspnea, moderate pain, severe pain, depression, and anxiety. The approved algorithms represented the consensus of multidisciplinary clinicians on pharmacological and behavioral interventions tailored to the patient's age, comorbidities, laboratory values, current medications, and patient-reported symptom severity. Algorithms also were reconciled with one another to enable simultaneous management of several symptoms. CONCLUSION: A modified ADAPTE process and nominal group technique enabled the development and approval of locally adapted computable algorithms for individualized symptom management in patients with lung cancer. The process was more complex and required more time and resources than initially anticipated, but it resulted in computable algorithms that represented the consensus of many experts.
Authors: Béatrice Fervers; Jako S Burgers; Margaret C Haugh; Jean Latreille; Najoua Mlika-Cabanne; Louise Paquet; Martin Coulombe; Mireille Poirier; Bernard Burnand Journal: Int J Qual Health Care Date: 2006-06 Impact factor: 2.038
Authors: Raymond Viola; Cathy Kiteley; Nancy S Lloyd; Jean A Mackay; Julie Wilson; Rebecca K S Wong Journal: Support Care Cancer Date: 2008-01-24 Impact factor: 3.603
Authors: S L Du Pen; A R Du Pen; N Polissar; J Hansberry; B M Kraybill; M Stillman; J Panke; R Everly; K Syrjala Journal: J Clin Oncol Date: 1999-01 Impact factor: 44.544
Authors: V Mock; A Atkinson; A Barsevick; D Cella; B Cimprich; C Cleeland; J Donnelly; M A Eisenberger; C Escalante; P Hinds; P B Jacobsen; P Kaldor; S J Knight; A Peterman; B F Piper; H Rugo; P Sabbatini; C Stahl Journal: Oncology (Williston Park) Date: 2000-11 Impact factor: 2.990
Authors: Steven D Passik; Kenneth L Kirsh; Dale Theobald; Kathleen Donaghy; Elizabeth Holtsclaw; Sarah Edgerton; William Dugan Journal: J Pain Symptom Manage Date: 2002-09 Impact factor: 3.612
Authors: Mary E Cooley; Emanuele Mazzola; Niya Xiong; Fangxin Hong; David F Lobach; Ilana M Braun; Barbara Halpenny; Michael S Rabin; Ellis Johns; Kathleen Finn; Donna Berry; Ruth McCorkle; Janet L Abrahm Journal: J Pain Symptom Manage Date: 2021-12-16 Impact factor: 5.576
Authors: Mary E Cooley; Traci M Blonquist; Paul J Catalano; David F Lobach; Barbara Halpenny; Ruth McCorkle; Ellis B Johns; Ilana M Braun; Michael S Rabin; Fatma Zohra Mataoui; Kathleen Finn; Donna L Berry; Janet L Abrahm Journal: J Pain Symptom Manage Date: 2014-05-29 Impact factor: 3.612
Authors: David F Lobach; Ellis B Johns; Barbara Halpenny; Toni-Ann Saunders; Jane Brzozowski; Guilherme Del Fiol; Donna L Berry; Ilana M Braun; Kathleen Finn; Joanne Wolfe; Janet L Abrahm; Mary E Cooley Journal: JMIR Med Inform Date: 2016-11-08
Authors: Mary E Cooley; Janet L Abrahm; Donna L Berry; Michael S Rabin; Ilana M Braun; Joanna Paladino; Manan M Nayak; David F Lobach Journal: BMC Med Inform Decis Mak Date: 2018-05-29 Impact factor: 2.796